Angioimmunoblastic T-cell lymphoma

1 paper

Humans1

Trial sponsors

Ruijin Hospital
2 trialsPhase 4223 people
Zhengzhou University
1 trialPhase 434 people
National Cancer Institute
10 trialsPhase 2451 people
Fred Hutchinson Cancer Center
7 trialsPhase 2394 people
University of Washington
2 trialsPhase 272 people
Alliance for Clinical Trials in Oncology
1 trialPhase 2170 people
The Royal Marsden NHS Foundation Trust
1 trialPhase 287 people
City of Hope Medical Center
1 trialPhase 248 people

Latest

1 in 12 months

Cancer Treatment and Research Communications15 Oct

Age-related early mortality and competing-risk outcomes in angioimmunoblastic T-cell lymphoma: a SEER-based population study

Cohort study of 1,516 peopleBlood and immune system